Next Article in Journal
Adalimumab in Treating Refractory Livedoid Vasculopathy
Next Article in Special Issue
From Kiyoshi Shiga to Present-Day Shigella Vaccines: A Historical Narrative Review
Previous Article in Journal
Parental COVID-19 Vaccine Hesitancy for Children in Romania: National Survey
Previous Article in Special Issue
Pivotal Shigella Vaccine Efficacy Trials—Study Design Considerations from a Shigella Vaccine Trial Design Working Group
 
 
Review

Article Versions Notes

Vaccines 2022, 10(4), 548; https://doi.org/10.3390/vaccines10040548
Action Date Notes Link
article xml file uploaded 1 April 2022 09:40 CEST Original file -
article xml uploaded. 1 April 2022 09:40 CEST Update https://www.mdpi.com/2076-393X/10/4/548/xml
article pdf uploaded. 1 April 2022 09:40 CEST Version of Record https://www.mdpi.com/2076-393X/10/4/548/pdf
article html file updated 1 April 2022 09:42 CEST Original file -
article html file updated 2 August 2022 16:53 CEST Update https://www.mdpi.com/2076-393X/10/4/548/html
Back to TopTop